Johnson Matthey (LON:JMAT) Announces Quarterly Earnings Results

Johnson Matthey logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Johnson Matthey raised its FY2026/27 outlook to high-single-digit growth in underlying operating profit, excluding Catalyst Technologies and Cormetech; management also cited expected benefits from metal prices and Cormetech.
  • Clean Air operating profit grew 26%, with margins rising 180 basis points to 14.2%. Clean Power’s revenue outlook increased to at least £250 million, and its Cormetech order book through March 2028 reached £350 million.
  • First-half free cash flow was a £98 million outflow, largely due to temporary working-capital needs; management expects a second-half unwind and full-year cash flow above last year’s £168 million. The U.K. PGM refinery’s full ramp-up was delayed to early 2028.
  • Interested in Johnson Matthey? Here are five stocks we like better.

Johnson Matthey (LON:JMAT - Get Free Report) posted its earnings results on Thursday. The company reported GBX 102.20 earnings per share for the quarter, Digital Look Earnings reports. Johnson Matthey had a negative net margin of 0.76% and a negative return on equity of 4.66%. The business had revenue of GBX 720.60 billion for the quarter.

Here are the key takeaways from Johnson Matthey's conference call:

  • Johnson Matthey upgraded its FY2026/27 outlook to high-single-digit growth in underlying operating profit, excluding Catalyst Technologies and Cormetech at constant currency and metal prices. It also expects a £35 million benefit from metal prices and around £20 million of operating contribution from Cormetech.
  • Clean Air delivered strong growth: operating profit rose 26% and margins increased 180 basis points to 14.2%. Management expects further margin progress and reiterated its 16%–18% margin target for 2027/28, while noting that market volumes will influence where it lands within that range.
  • The new Clean Power business is gaining momentum, with its revenue outlook raised to at least £250 million and margins expected to be at least mid-teens. Its order book for Cormetech through March 2028 has reached £350 million, although the business is benefiting heavily from current U.S. data-center demand.
  • First-half free cash flow was a £98 million outflow, mainly due to temporary working-capital needs around a U.S. refinery stock take. Management expects that working capital to unwind in the second half and full-year free cash flow to exceed last year’s £168 million; it also reiterated plans for at least £200 million of shareholder returns annually.
  • Full ramp-up of the new U.K. PGM refinery has shifted from calendar 2027 to early 2028, with management expecting modest additional CapEx. Hydrogen Technologies revenue also fell 26% and is expected to remain soft in the second half, though the company still targets break-even operating profit for the year.

Johnson Matthey Price Performance

Shares of Johnson Matthey stock opened at GBX 2,374 on Thursday. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. Johnson Matthey has a twelve month low of GBX 2,192 and a twelve month high of GBX 3,245.33. The firm has a market cap of £2.95 billion, a PE ratio of -31.13, a P/E/G ratio of 49,242.50 and a beta of 0.88. The business has a 50-day moving average price of GBX 2,395.10 and a 200 day moving average price of GBX 2,156.14.

Insider Activity at Johnson Matthey

In related news, insider Richard Pike bought 12 shares of the firm's stock in a transaction on Wednesday, November 11th. The shares were bought at an average price of GBX 2,433 per share, with a total value of £291.96. Also, insider Liam Condon bought 10,951 shares of the company's stock in a transaction that occurred on Friday, September 11th. The stock was acquired at an average cost of GBX 2,306 per share, for a total transaction of £252,530.06. In the last three months, insiders bought 28,628 shares of company stock valued at $64,999,052. Corporate insiders own 0.78% of the company's stock.

Analysts Set New Price Targets

JMAT has been the subject of a number of recent analyst reports. Berenberg Bank upped their price target on shares of Johnson Matthey from GBX 2,300 to GBX 2,550 and gave the company a "buy" rating in a report on Wednesday, October 28th. Jefferies Financial Group reissued a "buy" rating and issued a GBX 2,770 price objective on shares of Johnson Matthey in a report on Thursday, November 12th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of GBX 2,458.

View Our Latest Report on JMAT

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Stories

Earnings History for Johnson Matthey (LON:JMAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Johnson Matthey Right Now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines